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Most, but not all, studies report a positive association between birth weight, as 
an indirect marker of prenatal hormone exposure, and offspring breast cancer risk, 
particularly premenopausal breast cancer. Females from opposite-sexed twin pairs 
may also be prenatally exposed to androgens from their twin brothers. A Swedish 
study of opposite-sexed twins with a small sample size found a very strong positive 
association between female birth weight and breast cancer risk. In this case–con-
trol study, nested within a cohort of female opposite-sexed twins, we included 543 
breast cancer case subjects diagnosed in the period from 1972 to 2008 and 2715 
matched control subjects. Conditional logistic regression estimated the breast can-
cer risk associated with birth weight and other birth characteristics, including gesta-
tional age and co-twin birth weight. All statistical tests were two-sided. There was no 
association between birth weight (odds ratio = 1.01; 95% confidence interval = 0.70 
to 1.46) or twin brother’s birth weight and risk of breast cancer, which suggests the 
previously reported strong positive association may have been a chance finding.
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Birth weight, an indirect measure of estro-
gen exposure in utero (1–5), is generally 
(1,6–10), but not always (11–14), positively 
associated with the offspring’s risk of breast 
cancer, particularly premenopausal breast 
cancer (4,15–24). Moreover, findings from 
a twin study suggested that the associa-
tion is not confounded by familial (shared 
genetic or environmental) factors (20). 
A previous Swedish case–control study of 
opposite-sexed twins found a very strong 
positive association between female birth 
weight and subsequent risk of breast can-
cer (1). Given that the study only included 
90 case patients, this could be a chance 
finding.
It has also been shown that there is an 
association between levels of circulating 
androgens and risk of breast cancer (25–27). 
If female twins in opposite-sexed twin pairs 
are prenatally exposed to androgens from 
their twin brothers, this may influence their 
breast cancer risk.
This case–control study, nested within 
a cohort of opposite-sexed twins, inves-
tigated associations between female and 
male co-twin birth weight and risk of 
breast cancer, stratified by age (≤50 or 
>50 years) at diagnosis. The Swedish Twin 
Registry includes data on anthropometric 
measures at birth, date of last menstrual 
period, maternal age, parity, and the occu-
pational status of parents (28,29). The 
Swedish Cancer Registry contains indi-
vidual data on all newly diagnosed malig-
nant tumors in Sweden since 1958 and is 
more than 98% complete (30). Using the 
national registration number, a unique 
personal identifier, it is possible to link 
information across registries.
From the Swedish Twin Registry, we 
retrieved data on 13  075 pairs of oppo-
site-sexed twins born during the period 
from 1926 to 1972, with information on 
birth characteristics. Within this cohort 
we performed a nested case–control 
study, including all breast cancer case sub-
jects diagnosed between 1972 and 2008. 
Subjects with breast cancer were indi-
vidually matched by year of birth with five 
control subjects who were not affected by 
breast cancer and were alive at the time 
their matched case subject received a diag-
nosis of breast cancer (31). In total, there 
were 543 breast cancer case subjects and 
2715 control subjects (Table 1). This pro-
vides more than 90% statistical power to 
detect whether the mean birth weight of 
the case and control subjects differs by at 
least 100 grams (alpha  =  0.05; standard 
deviation = 500 grams).
 Socioeconomic status was based on 
the father’s profession at the time of birth 
(unskilled blue-collar worker, skilled 
blue-collar worker, low-level white-collar 
worker, intermediate-level white-collar 
worker, high-level white-collar worker, 
or self-employed); the mother’s profes-
sion was used if the father’s profession was 
missing.
Conditional logistic regression esti-
mated odds ratios (ORs) and 95% con-
fidence interval (CIs) for the association 
between birth weight and risk of breast 
cancer. We estimated the odds ratios using 
birth weight as both a continuous variable 
(risk increase per kilogram increase in birth 
weight) and a five-category (<2000, 2000–
2499, 2500–2999, 3000–3499, and ≥3500 
grams) variable.
Starting with the crude model, we 
consecutively adjusted for potential con-
founding factors in three different models 
(Table 2). The number of case/control sub-
jects with missing information for mater-
nal parity and socioeconomic status were 
45/225 and 167/897, respectively. We used 
multiple imputation methods to deal with 
the missing values (32). The Box–Tidwell 
test was used to test for nonlinearity of con-
tinuous variables.
We also estimated the risk associated 
with co-twin birth weight and investigated 
the interaction between female sex and 
co-twin birth weight. Moreover, the asso-
ciation between difference in birth weight 
between the brother and sister in the twin 
pair, as a continuous or categorical variable 
(500-gram categories), and breast cancer 
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Table 1. Characteristics, crude odds ratio (OR), and 95% confidence interval (CI) of breast cancer in female twins in opposite-sexed Swedish 
twin pairs, diagnosed at age 50 years or earlier and after age 50 years*
Characteristic
All subjects Aged ≤50 y Aged >50 y
Case subjects 
(n = 543)  
No. (%)
Control subjects 
(n = 2715)  
No. (%) OR (95% CI)
Case/Control 
subjects, No. OR (95% CI)
Case/Control 
subjects, No. OR (95% CI)
Birth characteristics
Birth weight, g
 <2000 43 (7.9) 210 (7.7) 0.98 (0.69 to 1.40) 17/77 1.11 (0.62 to 1.98) 26/133 0.88 (0.56 to 1.40)
 2000–2499 156 (28.7) 770 (28.4) 0.97 (0.78 to 1.22) 59/262 1.06 (0.72 to 1.55) 97/508 0.88 (0.66 to 1.17)
 2500–2999 212 (39.0) 1017 (37.5) Referent 74/372 Referent 138/645 Referent
 3000–3499 104 (19.2) 604 (22.3) 0.83 (0.64 to 1.07) 40/222 0.81 (0.53 to 1.25) 64/382 0.78 (0.56 to 1.08)
 ≥3500 28 (5.2) 114 (4.2) 1.18 (0.76 to 1.83) 13/42 1.56 (0.80 to 3.05) 15/72 0.97 (0.54 to 1.75)
 Continuous, kg 543 2715 0.96 (0.80 to 1.16) 203/975 0.95 (0.70 to 1.31) 340/1740 0.97 (0.77 to 1.24)
Birth length, cm
 ≤46 176 (32.4) 774 (28.5) 1.16 (0.90 to 1.50) 74/285 1.34 (0.88 to 2.04) 102/489 1.07 (0.77 to 1.49)
 47–48 154 (28.4) 857 (31.6) 0.92 (0.71 to 1.20) 57/306 1.03 (0.67 to 1.59) 97/551 0.92 (0.66 to 1.27)
 49 86 (15.8) 446 (16.4) 0.98 (0.73 to 1.33) 25/158 0.86 (0.50 to 1.48) 61/288 1.09 (0.75 to 1.58)
 ≥50 122 (22.5) 623 (23.0) Referent 45/223 Referent 77/400 Referent
 Continuous, cm 543 2715 0.99 (0.95 to 1.02) 203/975 0.98 (0.93 to 1.04) 340/1740 0.99 (0.94 to 1.03)
 Missing 5 (0.9) 15 (0.6) — 2/3 — 3/12 —
Head circumference, 
cm
 ≤32 192 (35.4) 981 (36.1) 1.01 (0.76 to 1.35) 81/386 1.31 (0.79 to 2.15) 111/595 0.88 (0.61 to 1.26)
 33 126 (23.2) 632 (23.3) 1.03 (0.75 to 1.40) 44/211 1.30 (0.76 to 2.24) 82/421 0.93 (0.63 to 1.36)
 34 120 (22.1) 606 (22.3) 1.03 (0.75 to 1.40) 42/206 1.26 (0.73 to 2.18) 78/400 0.94 (0.64 to 1.38)
 ≥35 79 (14.6) 408 (15.0) Referent 26/153 Referent 53/255 Referent
 Continuous, cm 543 2715 0.99 (0.93 to 1.04) 203/975 0.95 (0.86 to 1.04) 340/1740 1.01 (0.94 to 1.09)
 Missing 26 (4.8) 88 (3.2) — 10/19 — 16/69 —
Gestational age, wk
 <33 14 (2.6) 62 (2.3) 1.11 (0.61 to 2.02) 7/20 1.37 (0.53 to 3.57) 7/42 0.87 (0.38 to 1.98)
 33–36 123 (22.7) 599 (22.1) 1.01 (0.80 to 1.28) 38/208 0.84 (0.56 to 1.26) 85/391 1.18 (0.88 to 1.58)
 37–38 262 (48.3) 1290 (47.5) Referent 107/464 Referent 155/826 Referent
 ≥39 144 (26.5) 764 (28.1) 0.93 (0.75 to 1.16) 51/283 0.80 (0.55 to 1.15) 93/481 1.04 (0.79 to 1.38)
 Continuous, wk 543 2715 0.98 (0.95 to 1.02) 203/975 0.98 (0.93 to 1.05) 340/1740 0.98 (0.94 to 1.03)
Twin characteristics
Co-twin birth 
weight, g
 <2000 42 (7.7) 162 (6.0) 1.25 (0.86 to 1.81) 18/61 1.31 (0.73 to 2.34) 24/101 1.23 (0.76 to 2.00)
 2000–2499 122 (22.5) 592 (21.8) 0.99 (0.78 to 1.26) 42/229 0.75 (0.50 to 1.14) 80/363 1.12 (0.82 to 1.51)
 2500–2999 210 (38.7) 1006 (37.1) Referent 82/347 Referent 128/659 Referent
 3000–3499 129 (23.8) 747 (27.5) 0.83 (0.65 to 1.05) 44/267 0.71 (0.47 to 1.06) 85/480 0.88 (0.66 to 1.19)
 ≥3500 39 (7.2) 207 (7.6) 0.91 (0.63 to 1.30) 16/70 0.96 (0.52 to 1.75) 23/137 0.86 (0.54 to 1.39)
 Continuous, kg 543 2715 0.82 (0.68 to 0.98) 203/975 0.80 (0.59 to 1.09) 340/1740 0.81 (0.65 to 1.03)
 Missing 1 (0.2) 1 (0.0) — 1/1 — 0/0 —
Maternal 
characteristics
Maternal age, y
 <25 93 (17.1) 453 (16.7) Referent 34/160 Referent 59/293 Referent
 25–29 170 (31.3) 765 (28.2) 1. 09 (0.82 to 1.44) 69/307 1. 03 (0.65 to 1.62) 101/458 1.08 (0.76 to 1.54)
 30–34 144 (26.5) 807 (29.7) 0. 87 (0.65 to 1.15) 53/269 0. 90 (0.56 to 1.44) 91/538 0. 84 (0.59 to 1.19)
 ≥35 135 (24.9) 690 (25.4) 0. 96 (0.72 to 1.28) 47/239 0. 85 (0.52 to 1.39) 88/451 0. 97 (0.67 to 1.38)
 Continuous, y 543 2715 0.99 (0.98 to 1.01) 203/975 0.98 (0.95 to 1.01) 340/1740 1.00 (0.98 to 1.02)
 Missing 1 (0.2) 0 (0.0) — 0/0 — 1/0 —
Maternal parity
 Unipara 232 (42.7) 1086 (40.0) 1.29 (0.93 to 1.37) 75/358 0.98 (0.69 to 1.40) 157/728 1.19 (0.94 to 1.51)
 Multipara 266 (49.0) 1404 (51.7) Referent 83/392 Referent 183/1012 Referent
 Missing 45 (8.3) 225 (8.3) — 45/225 — 0/0 —
Hypertensive 
disease during 
pregnancy
 Yes 28 (5.2) 140 (5.2) 1.00 (0.66 to 1.52) 15/70 1.00 (0.55 to 1.81) 13/70 0.96 (0.53 to 1.74)
 No 515 (94.8) 2575 (94.8) Referent 188/905 Referent 327/1670 Referent
* Conditional logistic regression was used to analyze the data using two-sided alpha of 0.05.
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risk was estimated. Because the etiology 
of pre- and postmenopausal breast cancer 
may differ, analyses were stratified by age 
at diagnosis, using 50 years as the cutoff for 
pre- and postmenopausal breast cancer.
All statistical tests were two-sided, and 
values less than .05 were considered to be 
statistically significant. All analyses were 
performed using SAS 9.2 statistical soft-
ware (SAS Inc, Cary, NC). The study was 
approved by the research ethics committee 
at Karolinska Institutet.
We found no associations between birth 
weight and other independent variables and 
breast cancer risk (Table 1). Stratified anal-
yses for premenopausal or postmenopausal 
breast cancer revealed no association.
There were no associations between 
birth weight (OR  =  1.01; 95% CI  =  0.70 
to 1.46) or co-twin birth weight and 
risk of premenopausal or postmenopau-
sal breast cancer in any of the crude or 
adjusted models (Table 2). Also, there were 
no associations between the difference in 
female and male birth weight and risks of 
premenopausal or postmenopausal breast 
cancer (data not shown). Analysis in which 
both female birth weight and co-twin 
birth weight were included in the model 
as continuous variables revealed no statisti-
cally significant association. There was no 
interaction between female and male birth 
weight for risk of premenopausal (P = .91) 
or postmenopausal breast cancer (P = .62).
Our findings are consistent with 
the results of several previous negative 
cohort (33–35) and case–control studies 
(6,11–13,36–39). Many original studies 
(9,15,16,21,23,40) and three meta-analyses 
(22,41,42) reported a modestly increased 
risk of breast cancer associated with high 
birth weight (9,15,16,21,23,40), particu-
larly for premenopausal breast cancer (15–
21,23,40). However, many studies suffer 
from a limited sample size, and publication 
bias cannot be ruled out.
An earlier Swedish study of breast cancer 
in opposite-sexed twins with 90 case–con-
trol pairs found a 12-fold higher risk when 
comparing the heaviest with the lightest 
twins (1). Because the previously published 
study and this study used similar informa-
tion and had similar design, they share study 
strengths and weaknesses with one nota-
ble exception: sample size. Therefore, it is 
conceivable that the results of the previous 
study may have been a chance finding.
Recall bias is not a concern because the 
data were collected at the time of delivery. We 
controlled for some important confounding 
factors during early life, such as maternal 
sociodemographic factors. However, we had 
no information on exposures between birth 
and breast cancer diagnosis, such as contra-
ceptives or hormone replacement therapy, 
which could be a confounding factor (43). 
Another limitation is that we used birth 
weight as a proxy for estrogen and other 
prenatal hormone exposures.
Table 2. Risk of breast cancer according to individual birth weight and co-twin birth weight, stratified by age at diagnosis*
Birth weight Case/control subject, No. OR (95% CI) Crude OR (95% CI) Model 1† OR (95% CI) Model 2‡ OR (95% CI) Model 3§
≤50 years
Birth weight, g
 <2000 17/77 1.11 (0.62 to 1.98) 1.11 (0.59 to 2.09) 1.09 (0.58 to 2.06) 1.08 (0.57 to 2.04)
 2000–2499 59/262 1.06 (0.72 to 1.55) 1.10 (0.74 to 1.63) 1. 09 (0.73 to 1.62) 1.07 (0.72 to 1.60)
 2500–2999 74/372 Referent Referent Referent Referent
 3000–3499 40/222 0.81 (0.53 to 1.25) 0.84 (0.54 to 1.30) 0.84 (0.54 to 1.30) 0.83 (0.53 to 1.30)
 ≥3500 13/42 1.56 (0.80 to 3.05) 1.70 (0.85 to 3.40) 1.72 (0.86 to 3.44) 1.75 (0.87 to 3.53)
 Continuous, kg 203/975 0.95 (0.70 to 1.31) 0.99 (0.69 to 1.42) 1.02 (0.71 to 1.47) 1.01 (0.70 to 1.46)
Co-twin birth weight, g
 <2000 18/61 1.31 (0.73 to 2.34) 1.26 (0.66 to 2.39) 1.26 (0.66 to 2.39) 1.22 (0.64 to 2.33)
 2000–2499 42/229 0.75 (0.50 to 1.14) 0.76 (0.49 to 1.17) 0.76 (0.49 to 1.17) 0.75 (0.48 to 1.16)
 2500–2999 82/347 Referent Referent Referent Referent
 3000–3499 44/267 0.71 (0.47 to 1.06) 0.71 (0.47 to 1.07) 0.71 (0.47 to 1.07) 0.71 (0.47 to 1.07)
 ≥3500 16/70 0.96 (0.52 to 1.75) 1.03 (0.55 to 1.94) 1.03 (0.55 to 1.94) 1.02 (0.54 to 1.94)
 Continuous, kg 203/975 0.80 (0.59 to 1.09) 0.78 (0.54 to 1.12) 0.79 (0.55 to 1.15) 0.79 (0.54 to 1.14)
>50 years
Birth weight, g
 <2000 26/133 0.88 (0.56 to 1.40) 0.85 (0.52 to 1.40) 0.84 (0.51 to 1.38) 0. 84 (0.51 to 1.38)
 2000–2499 97/508 0.88 (0.66 to 1.17) 0.85 (0.63 to 1.14) 0.85 (0.63 to 1.15) 0. 86 (0.64 to 1.16)
 2500–2999 138/645 Referent Referent Referent Referent
 3000–3499 64/382 0.78 (0.56 to 1.08) 0.79 (0.57 to 1.09) 0.78 (0.56 to 1.08) 0.77 (0.55 to 1.08)
 ≥3500 15/72 0.97 (0.54 to 1.75) 0.98 (0.54 to 1.78) 0.98 (0.54 to 1.79) 0.99 (0.54 to 1.80)
 Continuous, kg 340/1740 0.97 (0.77 to 1.24) 1.03 (0.79 to 1.35) 1.03 (0.78 to 1.36) 1.03 (0.78 to 1.36)
Co-twin birth weight, g
 <2000 24/101 1.23 (0.76 to 2.00) 1.30 (0.77 to 2.19) 1.29 (0.76 to 2.19) 1.28 (0.76 to 2.18)
 2000–2499 80/363 1.12 (0.82 to 1.51) 1.11 (0.81 to 1.52) 1.09 (0.80 to 1.50) 1.09 (0.79 to 1.49)
 2500–2999 128/659 Referent Referent Referent Referent
 3000–3499 85/480 0.88 (0.66 to 1.19) 0.88 (0.65 to 1.19) 0.87 (0.64 to 1.18) 0.87 (0.64 to 1.18)
 ≥3500 23/137 0.86 (0.54 to 1.39) 0.86 (0.53 to 1.39) 0.87 (0.54 to 1.42) 0.88 (0.54 to 1.43)
 Continuous, kg 340/1740 0.81 (0.65 to 1.03) 0.82 (0.63 to 1.07) 0.82 (0.63 to 1.07) 0.82 (0.63 to 1.07)
* Conditional logistic regression was used to analyze the data using two-sided alpha of 0.05. Multiple imputation analysis was used to deal with missing data. CI, 
confidence interval; OR, odds ratio.
† Model 1 adjusted for gestational age.
‡ Model 2 adjusted for gestational age, maternal age, parity, and hypertensive disease during pregnancy.
§ Model 3 adjusted for the variables in model 2 and socioeconomic status.
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In conclusion, we could not replicate 
the previously reported strong association 
between birth weight and breast cancer risk 
in opposite-sexed twins (1), which may have 
been a chance finding.
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